FDA
- Status: approved
🇺🇸 Ritlecitinib 20 mg in United States
Ritlecitinib 20 mg (ritlecitinib-20-mg) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 80000.00 per year
Ritlecitinib 20 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Ritlecitinib 20 mg approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Ritlecitinib 20 mg in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Ritlecitinib 20 mg cost in United States?
annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.